Research Analysts Set Expectations for MGRM Q1 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Zacks Small Cap issued their Q1 2025 EPS estimates for Monogram Orthopaedics in a report released on Thursday, March 13th. Zacks Small Cap analyst T. Kerr forecasts that the company will post earnings of ($0.10) per share for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Zacks Small Cap also issued estimates for Monogram Orthopaedics’ Q2 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.44) EPS and FY2026 earnings at ($0.16) EPS.

Monogram Orthopaedics (NASDAQ:MGRM) last issued its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.03.

Several other analysts have also issued reports on the stock. Roth Mkm started coverage on shares of Monogram Orthopaedics in a research note on Monday, December 9th. They issued a “buy” rating and a $4.00 target price for the company. Roth Capital upgraded shares of Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

Monogram Orthopaedics Trading Up 57.5 %

NASDAQ MGRM opened at $3.67 on Monday. The business has a fifty day simple moving average of $2.56 and a 200 day simple moving average of $2.49. Monogram Orthopaedics has a 12 month low of $1.53 and a 12 month high of $4.90. The firm has a market capitalization of $129.51 million, a P/E ratio of -7.81 and a beta of 1.66.

Institutional Trading of Monogram Orthopaedics

A number of institutional investors and hedge funds have recently modified their holdings of the business. Jane Street Group LLC bought a new position in Monogram Orthopaedics in the 4th quarter valued at $25,000. Wells Fargo & Company MN grew its position in Monogram Orthopaedics by 286.6% during the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock valued at $27,000 after buying an additional 8,597 shares during the period. Barclays PLC bought a new position in Monogram Orthopaedics during the third quarter valued at about $29,000. Orion Portfolio Solutions LLC purchased a new stake in Monogram Orthopaedics during the fourth quarter worth about $31,000. Finally, State Street Corp bought a new stake in Monogram Orthopaedics in the third quarter worth about $62,000. 0.45% of the stock is owned by hedge funds and other institutional investors.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.